Boddy A - Search Results

1

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.

English MW, Lowis SP, Peng B, Boddy A, Newell DR, Price L, Pearson AD. English MW, et al. Among authors: boddy a. Br J Cancer. 1996 Mar;73(6):776-80. doi: 10.1038/bjc.1996.135. Br J Cancer. 1996. PMID: 8611379 Free PMC article.

2

Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy.

Veal GJ, English MW, Grundy RG, Shakespeare C, Glaser A, Waters F, Holden V, O'Meara A, Michalski A, Howe K, Cole S, Boddy AV. Veal GJ, et al. Among authors: boddy av. Cancer Chemother Pharmacol. 2004 Oct;54(4):295-300. doi: 10.1007/s00280-004-0820-3. Epub 2004 May 4. Cancer Chemother Pharmacol. 2004. PMID: 15133627

3

Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide.

Thomas HD, Porter DJ, Bartelink I, Nobbs JR, Cole M, Elliott S, Newell DR, Calvert AH, Highley M, Boddy AV. Thomas HD, et al. Among authors: boddy av. Br J Clin Pharmacol. 2002 Jan;53(1):83-91. doi: 10.1046/j.0306-5251.2001.01513.x. Br J Clin Pharmacol. 2002. PMID: 11849199 Free PMC article. Clinical Trial.

4

The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in paediatric patients: a review.

Bin P, Boddy AV, English MW, Pearson AD, Price L, Tilby MJ, Newell DR. Bin P, et al. Among authors: boddy av. Anticancer Res. 1994 Nov-Dec;14(6A):2279-83. Anticancer Res. 1994. PMID: 7825959 Review.

5

Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children.

Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Boddy AV, et al. Cancer Res. 1993 Aug 15;53(16):3758-64. Cancer Res. 1993. PMID: 8339288

6

Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients.

Peng B, Boddy AV, Cole M, Pearson AD, Chatelut E, Rubie H, Newell DR. Peng B, et al. Among authors: boddy av. Eur J Cancer. 1995 Oct;31A(11):1804-10. doi: 10.1016/0959-8049(95)00382-s. Eur J Cancer. 1995. PMID: 8541105

7

Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration.

Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Boddy AV, et al. Cancer Chemother Pharmacol. 1996;38(2):147-54. doi: 10.1007/s002800050463. Cancer Chemother Pharmacol. 1996. PMID: 8616905

8

Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics.

Boddy AV, English M, Pearson AD, Idle JR, Skinner R. Boddy AV, et al. Eur J Cancer. 1996 Jun;32A(7):1179-84. doi: 10.1016/0959-8049(96)00019-6. Eur J Cancer. 1996. PMID: 8758250 Clinical Trial.

9

Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.

Peng B, Tilby MJ, English MW, Price L, Pearson AD, Boddy AV, Newell DR. Peng B, et al. Among authors: boddy av. Br J Cancer. 1997;76(11):1466-73. doi: 10.1038/bjc.1997.579. Br J Cancer. 1997. PMID: 9400943 Free PMC article.

10

Cisplatin pharmacokinetics in children with cancer.

Peng B, English MW, Boddy AV, Price L, Wyllie R, Pearson AD, Tilby MJ, Newell DR. Peng B, et al. Among authors: boddy av. Eur J Cancer. 1997 Oct;33(11):1823-8. doi: 10.1016/s0959-8049(97)00341-9. Eur J Cancer. 1997. PMID: 9470840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters